Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Oxaliplatin and Capecitabine Versus Follow-up After Resection of Colorectal Liver Metastases
The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2007
by Arbeitsgruppe Lebermetastasen und Tumoren.
Recruitment status was Active, not recruiting
Study NCT00156975 Information provided by Arbeitsgruppe Lebermetastasen und Tumoren
First Received on September 9, 2005. Last Updated on December 24, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Colorectal Neoplasms
Liver Metastases
Additional conditions recognized in this trial
Liver Neoplasms
Neoplasm Metastasis
Neoplasms
Neoplasms, Second Primary
More general conditions related to this trial
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Liver Diseases
Neoplasms by Site
Neoplastic Processes
Pathologic Processes
Rectal Diseases
Interventions listed in this trial
Capecitabine
Oxaliplatin
Additional drug interventions recognized in this trial
Fluorouracil
More general drug interventions related to this trial
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Arbeitsgruppe Lebermetastasen und Tumoren
Back to top of Main Content